The dyspareunia treatment market is expected to reach USD 792.84 million in 2025, driven by the increasing prevalence of painful intercourse in women and the rising demand for hormonal therapies, pain management solutions, and regenerative treatments. With the market projected to grow to USD 1.16 billion by 2033 at a CAGR of 4.90%, this episode explores advancements in vaginal health treatments, non-hormonal therapies, and emerging medical innovations improving patient care and quality of life.